Nicolle M. Gatto - Concepedia

Author

Nicolle M. Gatto

Also Known As

Gatto, Nicolle M., N M Gatto, N. Gatto, N. M Gatto, N. M. Gatto, N.M Gatto, N.M. Gatto, Nicolle M. Gatto, Nicolle Gatto, Nicolle M Gatto

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Columbia University Aetion (United States)Pfizer (United States)Engineering Information Foundation Harvard University

About

Nicolle M. Gatto is an author at Columbia University specializing in medicine, general epidemiology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	47
2	Business	1	1	63
3	Health Sciences	1	1	12
4	Public Health	1	1	13
5	Social Sciences	1	1	63

Nicolle M. Gatto

Publications

Citations

H-Index

Page 1

	Year	Citations
Risk of Perforation After Colonoscopy and Sigmoidoscopy: A Population-Based Study Nicolle M. Gatto, Harold Frucht, Vijaya Sundararajan, JNCI Journal of the National Cancer Institute	2003	518
Is the “well-defined intervention assumption” politically conservative? Sharon Schwartz, Seth J. Prins, Ulka B. Campbell, Social Science & Medicine Public PolicyBusinessPolicy InterventionGovernment InterventionsPolitical Behavior	2015	63
Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance Ashley Jaksa, James J. Wu, Páll Jónsson, Journal of Comparative Effectiveness Research	2021	56
A Structured Preapproval and Postapproval Comparative Study Design Framework to Generate Valid and Transparent Real‐World Evidence for Regulatory Decisions Nicolle M. Gatto, Robert F. Reynolds, Ulka B. Campbell Clinical Pharmacology & Therapeutics	2019	55
Association of Azithromycin Use With Cardiovascular Mortality Jonathan G. Zaroff, T. Craig Cheetham, Niki Palmetto, JAMA Network Open	2020	46
Extending the sufficient component cause model to describe the Stable Unit Treatment Value Assumption (SUTVA) Sharon Schwartz, Nicolle M. Gatto, Ulka B. Campbell Epidemiologic Perspectives & Innovations	2012	41
Real‐World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID‐19 Jessica M. Franklin, Kueiyu Joshua Lin, Nicolle M. Gatto, Clinical Pharmacology & Therapeutics	2021	40
Methodological comparison of marginal structural model, time‐varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture M. Sanni Ali, Rolf H. H. Groenwold, Svetlana V. Belitser, Pharmacoepidemiology and Drug Safety	2016	33
Distributional interaction: Interpretational problems when using incidence odds ratios to assess interaction Ulka B. Campbell, Nicolle M. Gatto, Sharon Schwartz Epidemiologic Perspectives & Innovations	2005	24
Redundant causation from a sufficient cause perspective Nicolle M. Gatto, Ulka B. Campbell Epidemiologic Perspectives & Innovations	2010	24

Page 1